Impact of Statins on Drug-Tolerant Biofilm of  Mycobacteria

Aparna gaur; K. J. Gohil

Impact of Statins on Drug-Tolerant Biofilm of Mycobacteria

Authors: Aparna gaur, K. J. Gohil

Unique Paper ID: 150390
Volume: 7
Issue: 5
PageNo: 149-159

Keywords: Mycobacterium tuberculosis; cholesterol; statins; biofilms

Abstract:
Tuberculosis is one of the 10 leading reasons for death on the earth. Tuberculosis is an airborne bacterial contamination brought by M. tuberculosis which influences any aspect of the body and most normally the lungs. M. tuberculosis has waxy covering on its cell surface basically because of the presence of mycolic acid. As of late, a few mycobacterial species, including M. tuberculosis, have been found to shape drug-tolerant biofilms in vitro through hereditarily controlled mechanisms. Bacterial biofilms are serious worldwide wellbeing worry because of their capacities to tolerate antibiotics, host defence systems. M. tuberculosis needs cholesterol to taint and get by inside the host. Host-directed therapies are a moderately new and promising way to deal with treatment of tuberculosis. Statins are inhibitors of HMG-CoA reductase, a rate-limiting enzyme of the cholesterol biosynthesis pathway, which catalyzes transformation of HMG-CoA reductase into mevalonate and have pleiotropic impacts, including wide reach immunomodulatory, anti-inflammatory and antimicrobial effects. It has been accounted that cells treated with statins are more resistant to M. tuberculosis disease. The point of this review to assemble the accessible logical information on the biofim development by Mycobacteria tuberculosis and impact of statins on M. tuberculosis and biofilms of microorganisms.

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 7
Issue: 5
PageNo: 149-159

Impact of Statins on Drug-Tolerant Biofilm of Mycobacteria

Available:https://ijirt.org/Article?manuscript=150390

11 Jan, 2022

EVALUATION OF MARKETED EFFERVESCENT TABLETS

13 Oct, 2021

Bacterial Biofilm Inhibitor

02 Aug, 2021

The risk of death caused by the use of norepinephrine-resistant hypotension in the condition of septic shock in a patient

02 Aug, 2021

COMPUTER AIDED DRUG DESIGN (CADD)

29 Jul, 2021

Impact : Of Second Wave Covid-19 In world

29 Jul, 2021

The use of milrinone for curing a chronic heart failure

26 Jul, 2021

Leprosy Disease review

20 Jul, 2021

Transdermal Drug Delivery System

13 Jul, 2021

IBUPROFEN: AN OVERVIEW

13 Jul, 2021

CHEMOTHERAPY FOR BREAST CANCER

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry